The Effect of Body Awareness Therapy on Postural Stability, Balance and Fear of Falling in Patients With COPD
1 other identifier
interventional
32
1 country
1
Brief Summary
Chronic obstructive pulmonary disease (COPD) is one of the serious diseases with a high prevalence and mortality, which adversely affects the quality of life, and is expected to rank third in the global burden of disease in 2020. Although the primary pathophysiology of the disease is pulmonary, it is emphasized that extrapulmonary involvement and comorbid conditions adversely affect the severity and prognosis of the disease. In the treatment guidelines for COPD, extrapulmonary systems and symptoms should also be evaluated. In this context, the number of studies on the effects of postural stability, balance and fall has increased recently, especially in COPD patients. Although the efficacy of pulmonary rehabilitation (PR) in COPD is well defined, it provides minimal gains in postural control and balance. Alternative therapies are needed to improve postural stability, balance and fall in COPD patients. Body Awareness Therapy (BAQ) is an alternative method developed by French exercise instructor and psychotherapist Jacques Dropsy in the early 1970s following the emergence of the concept of body awareness, adapted to rehabilitation programs by Swedish and Norwegian physiotherapists. Traditional physiotherapy methods are the basis of BAQ. In the treatment, sensory stimulation and movement quality, rhythm, coordination, breathing, relaxation, balance, coordination and proprioceptive exercises give more space. In the literature, BAQ decreases pain, fatigue, eating and sleep problems in chronic musculoskeletal or rheumatic pain, coronary artery disease and neurological patient groups. It is seen to increase the quality of exercise, coordination, balance, postural control, quality of life and the integration between mind-body. Movement awareness and mind-body-behavior interaction developed in BAQ can help regulate emotional, mental, social and behavioral factors that affect health. In addition to improving coping skills and cognitive behaviors among COPD patients, it can contribute to positive gains in better movement, respiratory control and balance. The aim of this study is to investigate the effect of BAQ, which is integrated into 8-week pulmonary rehabilitation sessions, on postural stability, balance and fall conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable asthma
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2019
CompletedFirst Posted
Study publicly available on registry
December 27, 2019
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2022
CompletedDecember 27, 2019
February 1, 2019
1 year
December 19, 2019
December 25, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Postural Stability
In our study, the postural stability levels of the cases will be evaluated with their feet wide open on the balance platform without any support. The subjects were asked to hold the ball at the midpoint of the circle on the screen opposite to the position and center of gravity of the individual and to keep it at the midpoint for 1 minute; During the measurement, right - left and anterior - posterior oscillations and overall performance levels of the subjects will be recorded.
8 weeks
Balance
Balance Master device will be used. Using a fixed 18 "x 60" force platform, the Balance Master determines the vertical force exerted by the patient's feet to measure the center of balance.
8 weeks
Fear of Falling
It will be evaluated by the Drop Efficacy Scale. ISI is a 10-item scale. They are asked to score between 1 and 10 to the questions. 1 means a lot of trust, 10 means no. A total score of 0 to 100 is obtained. If the total score is more than 70 points, there is fear of falling.
8 weeks
Secondary Outcomes (5)
Tiffeneau index for Pulmonary Function Test
8 weeks
The Medical Research Council Dyspnea Scale (mMRC) for dyspnea
8 weeks
6-Minute Walk Test (6MWT) for functional capacity
8 weeks
Chronic Obstructive Pulmonary Disease Assessment Test (CAT)
8 weeks
Self-Efficacy Scale for the assessment of disease compliance:
8 weeks
Study Arms (2)
PR+BAT Group
EXPERIMENTALIn addition to the PR program, the BAT will be administered to the experimental group by a physiotherapist with 5 years of experience in BAT for 8 weeks.
PR Group
ACTIVE COMPARATORPatients in the control groups will receive a 30-minute Pulmonary Rehabilitation (PR) program every day of the week for 8 weeks.
Interventions
The BAT for the participants was based on the works of Roxendal and Dropsy. Activities include relaxation exercises, breathing exercises, floor exercises for trunk and pelvic movements, weight transfer using extremities and proprioceptive movements. Movements will be made in various positions to determine the centerline of the body. All exercises will be started in the supine position to maximize proprioceptive motion feedback and minimize energy requirements during tasks. Movements will be taught in a series of lessons over a period of 8 weeks with advance advancement of selected movements depending on participant comfort.
Diaphragmatic breathing exercise Thoracic expansion exercises (Chest breathing and bilateral segmental breathing exercises) Inductive spirometry (Triflo®) exercise Cough development techniques
Eligibility Criteria
You may qualify if:
- Diagnosis of COPD according to GOLD and willingness to participate
- Age between 40-80 years
- Clinically stable period
- No serious hearing and vision problems
You may not qualify if:
- Patients with recurrent exacerbations reported (history of exacerbation in the last two months)
- Having cognitive impairment (less than 24 Mini Mental Test scores)
- Having diagnosed vision, hearing, vestibular or neurological problems that may affect balance
- Having diagnosed orthopedic problems affecting mobility or having a history of surgical intervention
- COPD patients receiving home oxygen therapy or frequent need of oxygen therapy
- Patients with exercise-induced dyspnea
- Patients with primary pulmonary hypertension or patients with pulmonary embolism
- Congestive heart failure and severe coronary patients with coronary artery disease or by-pass surgery due to coronary artery disease
- Patients with morbid obesity
- Presence of systemic disease involving the lung and lung that would previously cause dyspnea other than COPD
- Having received pulmonary rehabilitation in the last 12 months
- Presence of unstable cardiovascular disease
- SpO2\<90%
- Problems with understanding and co-operation in understanding tests
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Marmara University
Istanbul, 34000, Turkey (Türkiye)
Related Publications (1)
Karaca S, Yildiz Ozer A, Karakurt S, Polat MG. Effects of body awareness therapy on balance and fear of falling in patients with chronic obstructive pulmonary disease: a randomized controlled trial. Biopsychosoc Med. 2024 Feb 26;18(1):6. doi: 10.1186/s13030-024-00303-x.
PMID: 38409129DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seda Karaca, MsC
Marmara University
- STUDY CHAIR
Aysel Yıldız Özer, Ass.Prof.Dr.
Marmara University
- STUDY DIRECTOR
Sait Karakurt, Prof. Dr.
Marmara University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 19, 2019
First Posted
December 27, 2019
Study Start
February 1, 2020
Primary Completion
February 1, 2021
Study Completion
February 1, 2022
Last Updated
December 27, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share